Labshake search
Citations for R&D Systems :
1 - 50 of 2096 citations for LIF Leukemia Inhibitory Factor Human since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... and Leukemia inhibitory factor (LIF; R&D systems).
-
bioRxiv - Cell Biology 2019Quote: ... Leukemia inhibitory factor (LIF) from R&D systems (MN, USA), and Stattic from Selleckchem (TX ...
-
bioRxiv - Immunology 2020Quote: ... and 25 ng/mL recombinant human leukemia inhibitory factor (LIF; R&D Systems; Minneapolis, MN, USA). ICs for M2b polarization were generated by mixing 1 µL of a 1.32 mg/mL solution of bovine serum albumin (BSA ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 20 ng/mL human LIF (R&D system, 225-SC).
-
bioRxiv - Bioengineering 2021Quote: ... and 100 U/mL Penicillin/Streptomycin supplemented with 0.1% recombinant human Fetal Growth Factor b (Alamone F-170) and 0.1% recombinant human Epidermal Growth Factor (R&D systems 236-EG). On Day 12 ...
-
bioRxiv - Molecular Biology 2021Quote: ... recombinant human epidermal growth factor (R&D systems, USA); IFN-γ (Cell Sciences ...
-
bioRxiv - Developmental Biology 2021Quote: ... Human N2B27-LCDM medium consisted of N2B27 basal medium supplemented with 10 ng/mL human LIF (R&D Systems, 7734), 3µM CHIR99021 (Tocris ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant human brain-derived neurotrophic factor (BDNF; R&D systems), and nerve growth factor (NGF) ...
-
bioRxiv - Neuroscience 2020Quote: ... recombinant human basic fibroblast growth factor (bFGF; R&D systems), fibroblast growth factor-8 (FGF-8 ...
-
bioRxiv - Cell Biology 2019Quote: ... 50 ng/ml human epidermal growth factor (R&D systems), 15 nM gastrin ...
-
bioRxiv - Systems Biology 2021Quote: ... 50ng/mL human fibroblastic growth factor 10 (R&D system), 5% FBS ...
-
bioRxiv - Biochemistry 2022Quote: ... with human recombinant nerve growth factor β (R&D Systems) and with bovine histone III (Sigma-Aldrich) ...
-
bioRxiv - Molecular Biology 2022Quote: ... 50 ng/mL recombinant human stem cell factor (R&D systems), 3 IU/mL Epoetin-alfa (Amgen) ...
-
bioRxiv - Biochemistry 2022Quote: ... recombinant human nerve growth factor-β (R&D Systems, Minneapolis, MIN); LysM (from Enterococcus faecalis ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Cancer Biology 2024Quote: ... with the exception of human epidermal growth factor (R&D Systems), bovine pituitary extract (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Biochemistry 2024Quote: ... LIF (R&D systems, AF449), VEGF-R2 (cell signaling ...
-
Tuning trophoblast invasion in a gelatin hydrogel via soluble cues from the maternal-fetal interfacebioRxiv - Bioengineering 2020Quote: ... Recombinant human transforming growth factor β1 (TGFβ1; R&D Systems, 240-B) and recombinant human epidermal growth factor (EGF ...
-
bioRxiv - Biochemistry 2021Quote: ... and human epidermal growth factor and TGFα were purchased (R&D Systems) and resuspended in buffer A.
-
bioRxiv - Cell Biology 2022Quote: ... human basic fibroblast growth factor (bFGF, 10 ng/ml, R&D Systems), and human fibroblast growth factor 10 (FGF10 ...
-
bioRxiv - Bioengineering 2022Quote: ... and human fibroblast growth factor 2 (20 ng/mL, R&D Systems). hECSR was added to the bottom channel prior to addition of cells into the well ...
-
bioRxiv - Biochemistry 2019Quote: ... Recombinant human fibroblast growth factor basic was purchased from R&D Systems, Inc ...
-
bioRxiv - Molecular Biology 2023Quote: ... human recombinant basic fibroblast growth factor (bFGF; R&D Systems Europe, Ltd.), human leukemia inhibitory factor (Millipore ...
-
bioRxiv - Developmental Biology 2023Quote: ... 50 ng/ml recombinant human epidermal growth factor (rhEGF; R&D Systems), 2 µM CHIR99021 (Tocris ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10ng/ml human basic fibroblast growth factor (bFGF, R&D systems). For the RedSox2 NSC characterization ...
-
bioRxiv - Molecular Biology 2021Quote: Recombinant human transforming growth factor-β (TGF-β) and fibroblast growth factor-2 FGF-2 were purchased from R&D Systems. BTZ ...
-
bioRxiv - Developmental Biology 2021Quote: ... LIF (7734-LF, R&D Systems), CNTF (257-NT ...
-
bioRxiv - Neuroscience 2019Quote: ... and human recombinant basic fibroblast growth factor (40 ng/ml; R&D Systems) on plates pre-coated with poly-l-ornithine (50 µg/ml ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant human epidermal growth factor (EGF) was from R&D Systems (Abingdon, UK).
-
bioRxiv - Cell Biology 2022Quote: ... and human fibroblast growth factor 10 (FGF10, 50 ng/ml, R&D Systems). The medium was changed every other day ...
-
bioRxiv - Cancer Biology 2022Quote: ... supplemented with human stem cell factor (SCF, 100 ng/mL, R&D Systems), human interleukin-3 (IL-3 ...
-
bioRxiv - Neuroscience 2019Quote: ... 100ng/mL recombinant human fibroblast growth factor 8a (FGF-8a, R&D system) from day 2 to day 11 ...
-
bioRxiv - Biochemistry 2019Quote: The corneal micropocket assay was performed as described16 using pellets containing 80 ng of basic fibroblast growth factor (bFGF) or 180 ng of human carrier-free recombinant vascular endothelial growth factor (VEGF; R&D Systems) in C57BL/6J mice ...
-
bioRxiv - Developmental Biology 2021Quote: ... 10 ng/ml LIF (R&D Systems), 10 ng/ml CNTF (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: The recombinant human transforming growth factor beta (TGFβ) protein and recombinant human TSP2 protein were obtained from R&D Systems. The SMAD3 Inhibitor SIS3 was procured from Cayman Chemical Company ...
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Bioengineering 2020Quote: Proteome Profiler Antibody Array Kits for human angiogenesis factors (R&D systems, MN, USA) were used for reverse western blot ...
-
bioRxiv - Cell Biology 2022Quote: ... together with human vascular endothelial growth factor (hVEGF, 5 ng/ml; R&D Systems). Cardiac specification was induced by exposure of cells to StemPro-34 SF medium (Gibco ...
-
bioRxiv - Immunology 2020Quote: ... 4 ng/ml human transforming growth factor α (TGFα; R&D Systems, MN, USA) as a positive control ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 10 ng/ml LIF (R&D Systems). Cells were maintained at 37 °C in 5% CO2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 25 ng/ml human macrophages colony-stimulating factor (M-CSF) (R&D Systems) for 4 days to stimulate macrophage differentiation ...
-
bioRxiv - Microbiology 2024Quote: ... and differentiated into M1 or M2 macrophages by incubation for 7 days in the presence of 100 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-colony stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA), respectively.
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...